LITRAMINE Trademark

Trademark Overview

On Monday, October 22, 2012, a trademark application was filed for LITRAMINE with the United States Patent and Trademark Office. The USPTO has given the LITRAMINE trademark a serial number of 85759525. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, August 31, 2019. This trademark is owned by INQPHARM EUROPE LIMITED. The LITRAMINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, nutraceutical, and other preparations, namely, nutritional supplements for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity; chemical preparations for pharmaceutical or medical purposes for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity; dietary supplement; medicinal plant extracts adapted for dietetic, nutraceutical, medical, nutritional and pharmaceutical use for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity
litramine

General Information

Serial Number85759525
Word MarkLITRAMINE
Filing DateMonday, October 22, 2012
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, August 31, 2019
Registration Number4573049
Registration DateTuesday, July 22, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2013

Trademark Statements

Goods and ServicesPharmaceutical, nutraceutical, and other preparations, namely, nutritional supplements for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity; chemical preparations for pharmaceutical or medical purposes for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity; dietary supplement; medicinal plant extracts adapted for dietetic, nutraceutical, medical, nutritional and pharmaceutical use for the treatment of metabolic syndrome and related diseases, general weight management and the treatment of obesity
Translation of Words in MarkThe word "LITRAMINE" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 25, 2012
Primary Code005
First Use Anywhere DateTuesday, September 30, 2008
First Use In Commerce DateWednesday, October 13, 2010

Trademark Owner History

Party NameINQPHARM EUROPE LIMITED
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB
Party NameINQPHARM EUROPE LIMITED
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB
Party NameINQPHARM EUROPE LIMITED
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHitchin, Hertfordshire SG40TY
GB

Trademark Events

Event DateEvent Description
Thursday, October 25, 2012NEW APPLICATION ENTERED
Friday, August 16, 2013ASSIGNED TO LIE
Friday, August 23, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 23, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2013ASSIGNED TO EXAMINER
Thursday, October 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 20, 2013ASSIGNED TO EXAMINER
Thursday, February 21, 2013NON-FINAL ACTION WRITTEN
Thursday, February 21, 2013NON-FINAL ACTION E-MAILED
Thursday, February 21, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 14, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 26, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 20, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 27, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 28, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 11, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 1, 2013PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, April 25, 2014TEAS STATEMENT OF USE RECEIVED
Friday, April 25, 2014USE AMENDMENT FILED
Friday, April 25, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 21, 2014STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 23, 2019TEAS SECTION 8 & 15 RECEIVED
Saturday, August 31, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, August 31, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, August 31, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 22, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, July 18, 2024TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 11, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 14, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, June 17, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 22, 2014REGISTERED-PRINCIPAL REGISTER
Monday, July 22, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 7, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 26, 2025TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Saturday, August 23, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Thursday, January 2, 2025POST REGISTRATION ACTION MAILED - SEC. 8 & 9

Related Keywords

litramine treatment diseases related pharmaceutical weight obesity management syndrome general metabolic